CMC Consulting Group, an international consulting firm with six offices in Europe, will early next year rebrand to Alira Health. The new name, in particular the reference to ‘Health’, better reflects the firm’s specialised focus on the healthcare and life sciences industries, says CEO Gabriele Brambilla.
Since its inception in Germany, CMC Consulting Group has grown from a boutique advisory firm – the company was founded in 1999 in Wurmlingen – to an international consultancy with offices in Europe (six) and the United States (one). Today, CMC operates with four services lines – Management Consulting, Transaction Advisory, Medical Affairs and Drug & Device Discovery Lab – all of which are geared at three sectors: medical, healthcare and pharmaceuticals.
After seventeen years of operating as CMC Consulting Group, the privately-held consultancy has decided to make a name change for the better, according to Gabriele Brambilla, an Italian who has been at the helm of the firm since the summer of 2014. “As a company rooted in healthcare and life sciences, Alira Health’s new identity gives us the opportunity to articulate our leadership in innovative healthcare solutions more accurately,” he remarks. The rebranding in addition is touted to support the firm’s expanded positioning – CMC Consulting Group has of late extended its service portfolio to serve payers and healthcare providers, above its traditional client base of product and solution suppliers.
The new brand identity will be adopted effective January 1, 2017, and be rolled out across the firm’s network in Munich, Amsterdam, Paris, Milan, Barcelona, Boston and Poznan. Although the change, at the outset, marks a major milestone for CMC, the transition will have little impact on the firm’s offerings, people and DNA, says Benjamin Chambon, COO of the business advisory. “Despite our name and logo changing, we are the same team of talented strategy experts with science, medicine and innovation at our core.”
Earlier this year CMC advised on two deals in the healthcare space: the sale of LaunchWorks Manufacturing Lab to Edison, New Jersey (US) headquartered TCP Reliable (sell-side advisory) and the sale of Italy-based Mitim to pharmaceutical player Recipharm (sell-side M&A advisory).